SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013271
Filing Date
2022-08-11
Accepted
2022-08-11 16:06:26
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alt-20220630x10q.htm   iXBRL 10-Q 1212834
2 EX-31.1 alt-20220630xex31d1.htm EX-31.1 11937
3 EX-31.2 alt-20220630xex31d2.htm EX-31.2 11780
4 EX-32.1 alt-20220630xex32d1.htm EX-32.1 6757
5 EX-32.2 alt-20220630xex32d2.htm EX-32.2 6887
6 GRAPHIC alt-20220630x10q002.jpg GRAPHIC 16725
  Complete submission text file 0001558370-22-013271.txt   5223872

Data Files

Seq Description Document Type Size
7 EX-101.SCH alt-20220630.xsd EX-101.SCH 42724
8 EX-101.CAL alt-20220630_cal.xml EX-101.CAL 40728
9 EX-101.DEF alt-20220630_def.xml EX-101.DEF 149724
10 EX-101.LAB alt-20220630_lab.xml EX-101.LAB 379009
11 EX-101.PRE alt-20220630_pre.xml EX-101.PRE 270521
60 EXTRACTED XBRL INSTANCE DOCUMENT alt-20220630x10q_htm.xml XML 780746
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 221155686
SIC: 2834 Pharmaceutical Preparations